Global Drug-Eluting Stent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Drug-Eluting Stent market size was valued at USD 6126.3 million in 2022 and is forecast to a readjusted size of USD 7715.4 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Drug-Eluting Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drug-Eluting Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug-Eluting Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug-Eluting Stent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Medtronic, Abbott, Lepu Medical and B. Braun Melsungen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Drug-Eluting Stent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Drug-Eluting Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug-Eluting Stent, with price, sales, revenue and global market share of Drug-Eluting Stent from 2018 to 2023.
Chapter 3, the Drug-Eluting Stent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Eluting Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Drug-Eluting Stent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Eluting Stent.
Chapter 14 and 15, to describe Drug-Eluting Stent sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Drug-Eluting Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Drug-Eluting Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Drug-Eluting Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug-Eluting Stent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug-Eluting Stent market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Medtronic, Abbott, Lepu Medical and B. Braun Melsungen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Drug-Eluting Stent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Rapamycin Eluting Stent
- Paclitaxel Eluting Stent
- Everolimus Eluting Stent
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Boston Scientific
- Medtronic
- Abbott
- Lepu Medical
- B. Braun Melsungen
- MicroPort Scientific
- Cook Medical
- Terumo
- Biosensors International
- Balton
- AlviMedica Medical Technologies
- Biotronik
- Shandong JW Medical
- Sino Medical
- Beijing AMSINO
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Drug-Eluting Stent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug-Eluting Stent, with price, sales, revenue and global market share of Drug-Eluting Stent from 2018 to 2023.
Chapter 3, the Drug-Eluting Stent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug-Eluting Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Drug-Eluting Stent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Eluting Stent.
Chapter 14 and 15, to describe Drug-Eluting Stent sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drug-Eluting Stent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rapamycin Eluting Stent
1.3.3 Paclitaxel Eluting Stent
1.3.4 Everolimus Eluting Stent
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Drug-Eluting Stent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.4.5 Others
1.5 Global Drug-Eluting Stent Market Size & Forecast
1.5.1 Global Drug-Eluting Stent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Drug-Eluting Stent Sales Quantity (2018-2029)
1.5.3 Global Drug-Eluting Stent Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Drug-Eluting Stent Product and Services
2.1.4 Boston Scientific Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boston Scientific Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Drug-Eluting Stent Product and Services
2.2.4 Medtronic Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Drug-Eluting Stent Product and Services
2.3.4 Abbott Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 Lepu Medical
2.4.1 Lepu Medical Details
2.4.2 Lepu Medical Major Business
2.4.3 Lepu Medical Drug-Eluting Stent Product and Services
2.4.4 Lepu Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lepu Medical Recent Developments/Updates
2.5 B. Braun Melsungen
2.5.1 B. Braun Melsungen Details
2.5.2 B. Braun Melsungen Major Business
2.5.3 B. Braun Melsungen Drug-Eluting Stent Product and Services
2.5.4 B. Braun Melsungen Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 B. Braun Melsungen Recent Developments/Updates
2.6 MicroPort Scientific
2.6.1 MicroPort Scientific Details
2.6.2 MicroPort Scientific Major Business
2.6.3 MicroPort Scientific Drug-Eluting Stent Product and Services
2.6.4 MicroPort Scientific Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MicroPort Scientific Recent Developments/Updates
2.7 Cook Medical
2.7.1 Cook Medical Details
2.7.2 Cook Medical Major Business
2.7.3 Cook Medical Drug-Eluting Stent Product and Services
2.7.4 Cook Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cook Medical Recent Developments/Updates
2.8 Terumo
2.8.1 Terumo Details
2.8.2 Terumo Major Business
2.8.3 Terumo Drug-Eluting Stent Product and Services
2.8.4 Terumo Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Terumo Recent Developments/Updates
2.9 Biosensors International
2.9.1 Biosensors International Details
2.9.2 Biosensors International Major Business
2.9.3 Biosensors International Drug-Eluting Stent Product and Services
2.9.4 Biosensors International Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biosensors International Recent Developments/Updates
2.10 Balton
2.10.1 Balton Details
2.10.2 Balton Major Business
2.10.3 Balton Drug-Eluting Stent Product and Services
2.10.4 Balton Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Balton Recent Developments/Updates
2.11 AlviMedica Medical Technologies
2.11.1 AlviMedica Medical Technologies Details
2.11.2 AlviMedica Medical Technologies Major Business
2.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Product and Services
2.11.4 AlviMedica Medical Technologies Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AlviMedica Medical Technologies Recent Developments/Updates
2.12 Biotronik
2.12.1 Biotronik Details
2.12.2 Biotronik Major Business
2.12.3 Biotronik Drug-Eluting Stent Product and Services
2.12.4 Biotronik Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biotronik Recent Developments/Updates
2.13 Shandong JW Medical
2.13.1 Shandong JW Medical Details
2.13.2 Shandong JW Medical Major Business
2.13.3 Shandong JW Medical Drug-Eluting Stent Product and Services
2.13.4 Shandong JW Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shandong JW Medical Recent Developments/Updates
2.14 Sino Medical
2.14.1 Sino Medical Details
2.14.2 Sino Medical Major Business
2.14.3 Sino Medical Drug-Eluting Stent Product and Services
2.14.4 Sino Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sino Medical Recent Developments/Updates
2.15 Beijing AMSINO
2.15.1 Beijing AMSINO Details
2.15.2 Beijing AMSINO Major Business
2.15.3 Beijing AMSINO Drug-Eluting Stent Product and Services
2.15.4 Beijing AMSINO Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Beijing AMSINO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DRUG-ELUTING STENT BY MANUFACTURER
3.1 Global Drug-Eluting Stent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Drug-Eluting Stent Revenue by Manufacturer (2018-2023)
3.3 Global Drug-Eluting Stent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Drug-Eluting Stent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Drug-Eluting Stent Manufacturer Market Share in 2022
3.4.2 Top 6 Drug-Eluting Stent Manufacturer Market Share in 2022
3.5 Drug-Eluting Stent Market: Overall Company Footprint Analysis
3.5.1 Drug-Eluting Stent Market: Region Footprint
3.5.2 Drug-Eluting Stent Market: Company Product Type Footprint
3.5.3 Drug-Eluting Stent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Drug-Eluting Stent Market Size by Region
4.1.1 Global Drug-Eluting Stent Sales Quantity by Region (2018-2029)
4.1.2 Global Drug-Eluting Stent Consumption Value by Region (2018-2029)
4.1.3 Global Drug-Eluting Stent Average Price by Region (2018-2029)
4.2 North America Drug-Eluting Stent Consumption Value (2018-2029)
4.3 Europe Drug-Eluting Stent Consumption Value (2018-2029)
4.4 Asia-Pacific Drug-Eluting Stent Consumption Value (2018-2029)
4.5 South America Drug-Eluting Stent Consumption Value (2018-2029)
4.6 Middle East and Africa Drug-Eluting Stent Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Drug-Eluting Stent Sales Quantity by Type (2018-2029)
5.2 Global Drug-Eluting Stent Consumption Value by Type (2018-2029)
5.3 Global Drug-Eluting Stent Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Drug-Eluting Stent Sales Quantity by Application (2018-2029)
6.2 Global Drug-Eluting Stent Consumption Value by Application (2018-2029)
6.3 Global Drug-Eluting Stent Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Drug-Eluting Stent Sales Quantity by Type (2018-2029)
7.2 North America Drug-Eluting Stent Sales Quantity by Application (2018-2029)
7.3 North America Drug-Eluting Stent Market Size by Country
7.3.1 North America Drug-Eluting Stent Sales Quantity by Country (2018-2029)
7.3.2 North America Drug-Eluting Stent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Drug-Eluting Stent Sales Quantity by Type (2018-2029)
8.2 Europe Drug-Eluting Stent Sales Quantity by Application (2018-2029)
8.3 Europe Drug-Eluting Stent Market Size by Country
8.3.1 Europe Drug-Eluting Stent Sales Quantity by Country (2018-2029)
8.3.2 Europe Drug-Eluting Stent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Drug-Eluting Stent Market Size by Region
9.3.1 Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Drug-Eluting Stent Sales Quantity by Type (2018-2029)
10.2 South America Drug-Eluting Stent Sales Quantity by Application (2018-2029)
10.3 South America Drug-Eluting Stent Market Size by Country
10.3.1 South America Drug-Eluting Stent Sales Quantity by Country (2018-2029)
10.3.2 South America Drug-Eluting Stent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Drug-Eluting Stent Market Size by Country
11.3.1 Middle East & Africa Drug-Eluting Stent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Drug-Eluting Stent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Drug-Eluting Stent Market Drivers
12.2 Drug-Eluting Stent Market Restraints
12.3 Drug-Eluting Stent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Drug-Eluting Stent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug-Eluting Stent
13.3 Drug-Eluting Stent Production Process
13.4 Drug-Eluting Stent Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drug-Eluting Stent Typical Distributors
14.3 Drug-Eluting Stent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Drug-Eluting Stent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drug-Eluting Stent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Rapamycin Eluting Stent
1.3.3 Paclitaxel Eluting Stent
1.3.4 Everolimus Eluting Stent
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Drug-Eluting Stent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.4.5 Others
1.5 Global Drug-Eluting Stent Market Size & Forecast
1.5.1 Global Drug-Eluting Stent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Drug-Eluting Stent Sales Quantity (2018-2029)
1.5.3 Global Drug-Eluting Stent Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Drug-Eluting Stent Product and Services
2.1.4 Boston Scientific Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boston Scientific Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Drug-Eluting Stent Product and Services
2.2.4 Medtronic Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic Recent Developments/Updates
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Drug-Eluting Stent Product and Services
2.3.4 Abbott Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Recent Developments/Updates
2.4 Lepu Medical
2.4.1 Lepu Medical Details
2.4.2 Lepu Medical Major Business
2.4.3 Lepu Medical Drug-Eluting Stent Product and Services
2.4.4 Lepu Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lepu Medical Recent Developments/Updates
2.5 B. Braun Melsungen
2.5.1 B. Braun Melsungen Details
2.5.2 B. Braun Melsungen Major Business
2.5.3 B. Braun Melsungen Drug-Eluting Stent Product and Services
2.5.4 B. Braun Melsungen Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 B. Braun Melsungen Recent Developments/Updates
2.6 MicroPort Scientific
2.6.1 MicroPort Scientific Details
2.6.2 MicroPort Scientific Major Business
2.6.3 MicroPort Scientific Drug-Eluting Stent Product and Services
2.6.4 MicroPort Scientific Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MicroPort Scientific Recent Developments/Updates
2.7 Cook Medical
2.7.1 Cook Medical Details
2.7.2 Cook Medical Major Business
2.7.3 Cook Medical Drug-Eluting Stent Product and Services
2.7.4 Cook Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cook Medical Recent Developments/Updates
2.8 Terumo
2.8.1 Terumo Details
2.8.2 Terumo Major Business
2.8.3 Terumo Drug-Eluting Stent Product and Services
2.8.4 Terumo Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Terumo Recent Developments/Updates
2.9 Biosensors International
2.9.1 Biosensors International Details
2.9.2 Biosensors International Major Business
2.9.3 Biosensors International Drug-Eluting Stent Product and Services
2.9.4 Biosensors International Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biosensors International Recent Developments/Updates
2.10 Balton
2.10.1 Balton Details
2.10.2 Balton Major Business
2.10.3 Balton Drug-Eluting Stent Product and Services
2.10.4 Balton Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Balton Recent Developments/Updates
2.11 AlviMedica Medical Technologies
2.11.1 AlviMedica Medical Technologies Details
2.11.2 AlviMedica Medical Technologies Major Business
2.11.3 AlviMedica Medical Technologies Drug-Eluting Stent Product and Services
2.11.4 AlviMedica Medical Technologies Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AlviMedica Medical Technologies Recent Developments/Updates
2.12 Biotronik
2.12.1 Biotronik Details
2.12.2 Biotronik Major Business
2.12.3 Biotronik Drug-Eluting Stent Product and Services
2.12.4 Biotronik Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biotronik Recent Developments/Updates
2.13 Shandong JW Medical
2.13.1 Shandong JW Medical Details
2.13.2 Shandong JW Medical Major Business
2.13.3 Shandong JW Medical Drug-Eluting Stent Product and Services
2.13.4 Shandong JW Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shandong JW Medical Recent Developments/Updates
2.14 Sino Medical
2.14.1 Sino Medical Details
2.14.2 Sino Medical Major Business
2.14.3 Sino Medical Drug-Eluting Stent Product and Services
2.14.4 Sino Medical Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sino Medical Recent Developments/Updates
2.15 Beijing AMSINO
2.15.1 Beijing AMSINO Details
2.15.2 Beijing AMSINO Major Business
2.15.3 Beijing AMSINO Drug-Eluting Stent Product and Services
2.15.4 Beijing AMSINO Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Beijing AMSINO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DRUG-ELUTING STENT BY MANUFACTURER
3.1 Global Drug-Eluting Stent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Drug-Eluting Stent Revenue by Manufacturer (2018-2023)
3.3 Global Drug-Eluting Stent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Drug-Eluting Stent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Drug-Eluting Stent Manufacturer Market Share in 2022
3.4.2 Top 6 Drug-Eluting Stent Manufacturer Market Share in 2022
3.5 Drug-Eluting Stent Market: Overall Company Footprint Analysis
3.5.1 Drug-Eluting Stent Market: Region Footprint
3.5.2 Drug-Eluting Stent Market: Company Product Type Footprint
3.5.3 Drug-Eluting Stent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Drug-Eluting Stent Market Size by Region
4.1.1 Global Drug-Eluting Stent Sales Quantity by Region (2018-2029)
4.1.2 Global Drug-Eluting Stent Consumption Value by Region (2018-2029)
4.1.3 Global Drug-Eluting Stent Average Price by Region (2018-2029)
4.2 North America Drug-Eluting Stent Consumption Value (2018-2029)
4.3 Europe Drug-Eluting Stent Consumption Value (2018-2029)
4.4 Asia-Pacific Drug-Eluting Stent Consumption Value (2018-2029)
4.5 South America Drug-Eluting Stent Consumption Value (2018-2029)
4.6 Middle East and Africa Drug-Eluting Stent Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Drug-Eluting Stent Sales Quantity by Type (2018-2029)
5.2 Global Drug-Eluting Stent Consumption Value by Type (2018-2029)
5.3 Global Drug-Eluting Stent Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Drug-Eluting Stent Sales Quantity by Application (2018-2029)
6.2 Global Drug-Eluting Stent Consumption Value by Application (2018-2029)
6.3 Global Drug-Eluting Stent Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Drug-Eluting Stent Sales Quantity by Type (2018-2029)
7.2 North America Drug-Eluting Stent Sales Quantity by Application (2018-2029)
7.3 North America Drug-Eluting Stent Market Size by Country
7.3.1 North America Drug-Eluting Stent Sales Quantity by Country (2018-2029)
7.3.2 North America Drug-Eluting Stent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Drug-Eluting Stent Sales Quantity by Type (2018-2029)
8.2 Europe Drug-Eluting Stent Sales Quantity by Application (2018-2029)
8.3 Europe Drug-Eluting Stent Market Size by Country
8.3.1 Europe Drug-Eluting Stent Sales Quantity by Country (2018-2029)
8.3.2 Europe Drug-Eluting Stent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Drug-Eluting Stent Market Size by Region
9.3.1 Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Drug-Eluting Stent Sales Quantity by Type (2018-2029)
10.2 South America Drug-Eluting Stent Sales Quantity by Application (2018-2029)
10.3 South America Drug-Eluting Stent Market Size by Country
10.3.1 South America Drug-Eluting Stent Sales Quantity by Country (2018-2029)
10.3.2 South America Drug-Eluting Stent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Drug-Eluting Stent Market Size by Country
11.3.1 Middle East & Africa Drug-Eluting Stent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Drug-Eluting Stent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Drug-Eluting Stent Market Drivers
12.2 Drug-Eluting Stent Market Restraints
12.3 Drug-Eluting Stent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Drug-Eluting Stent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug-Eluting Stent
13.3 Drug-Eluting Stent Production Process
13.4 Drug-Eluting Stent Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drug-Eluting Stent Typical Distributors
14.3 Drug-Eluting Stent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Drug-Eluting Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drug-Eluting Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Major Business
Table 5. Boston Scientific Drug-Eluting Stent Product and Services
Table 6. Boston Scientific Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boston Scientific Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Drug-Eluting Stent Product and Services
Table 11. Medtronic Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Drug-Eluting Stent Product and Services
Table 16. Abbott Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 19. Lepu Medical Major Business
Table 20. Lepu Medical Drug-Eluting Stent Product and Services
Table 21. Lepu Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lepu Medical Recent Developments/Updates
Table 23. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen Major Business
Table 25. B. Braun Melsungen Drug-Eluting Stent Product and Services
Table 26. B. Braun Melsungen Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. B. Braun Melsungen Recent Developments/Updates
Table 28. MicroPort Scientific Basic Information, Manufacturing Base and Competitors
Table 29. MicroPort Scientific Major Business
Table 30. MicroPort Scientific Drug-Eluting Stent Product and Services
Table 31. MicroPort Scientific Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MicroPort Scientific Recent Developments/Updates
Table 33. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 34. Cook Medical Major Business
Table 35. Cook Medical Drug-Eluting Stent Product and Services
Table 36. Cook Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cook Medical Recent Developments/Updates
Table 38. Terumo Basic Information, Manufacturing Base and Competitors
Table 39. Terumo Major Business
Table 40. Terumo Drug-Eluting Stent Product and Services
Table 41. Terumo Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Terumo Recent Developments/Updates
Table 43. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 44. Biosensors International Major Business
Table 45. Biosensors International Drug-Eluting Stent Product and Services
Table 46. Biosensors International Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biosensors International Recent Developments/Updates
Table 48. Balton Basic Information, Manufacturing Base and Competitors
Table 49. Balton Major Business
Table 50. Balton Drug-Eluting Stent Product and Services
Table 51. Balton Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Balton Recent Developments/Updates
Table 53. AlviMedica Medical Technologies Basic Information, Manufacturing Base and Competitors
Table 54. AlviMedica Medical Technologies Major Business
Table 55. AlviMedica Medical Technologies Drug-Eluting Stent Product and Services
Table 56. AlviMedica Medical Technologies Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. AlviMedica Medical Technologies Recent Developments/Updates
Table 58. Biotronik Basic Information, Manufacturing Base and Competitors
Table 59. Biotronik Major Business
Table 60. Biotronik Drug-Eluting Stent Product and Services
Table 61. Biotronik Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biotronik Recent Developments/Updates
Table 63. Shandong JW Medical Basic Information, Manufacturing Base and Competitors
Table 64. Shandong JW Medical Major Business
Table 65. Shandong JW Medical Drug-Eluting Stent Product and Services
Table 66. Shandong JW Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shandong JW Medical Recent Developments/Updates
Table 68. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 69. Sino Medical Major Business
Table 70. Sino Medical Drug-Eluting Stent Product and Services
Table 71. Sino Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sino Medical Recent Developments/Updates
Table 73. Beijing AMSINO Basic Information, Manufacturing Base and Competitors
Table 74. Beijing AMSINO Major Business
Table 75. Beijing AMSINO Drug-Eluting Stent Product and Services
Table 76. Beijing AMSINO Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Beijing AMSINO Recent Developments/Updates
Table 78. Global Drug-Eluting Stent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Drug-Eluting Stent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Drug-Eluting Stent Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Drug-Eluting Stent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Drug-Eluting Stent Production Site of Key Manufacturer
Table 83. Drug-Eluting Stent Market: Company Product Type Footprint
Table 84. Drug-Eluting Stent Market: Company Product Application Footprint
Table 85. Drug-Eluting Stent New Market Entrants and Barriers to Market Entry
Table 86. Drug-Eluting Stent Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Drug-Eluting Stent Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Drug-Eluting Stent Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Drug-Eluting Stent Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Drug-Eluting Stent Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Drug-Eluting Stent Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Drug-Eluting Stent Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Drug-Eluting Stent Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Drug-Eluting Stent Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Drug-Eluting Stent Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Drug-Eluting Stent Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Drug-Eluting Stent Raw Material
Table 146. Key Manufacturers of Drug-Eluting Stent Raw Materials
Table 147. Drug-Eluting Stent Typical Distributors
Table 148. Drug-Eluting Stent Typical Customers
Table 1. Global Drug-Eluting Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Drug-Eluting Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Major Business
Table 5. Boston Scientific Drug-Eluting Stent Product and Services
Table 6. Boston Scientific Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boston Scientific Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Drug-Eluting Stent Product and Services
Table 11. Medtronic Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic Recent Developments/Updates
Table 13. Abbott Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Major Business
Table 15. Abbott Drug-Eluting Stent Product and Services
Table 16. Abbott Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Abbott Recent Developments/Updates
Table 18. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 19. Lepu Medical Major Business
Table 20. Lepu Medical Drug-Eluting Stent Product and Services
Table 21. Lepu Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lepu Medical Recent Developments/Updates
Table 23. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Melsungen Major Business
Table 25. B. Braun Melsungen Drug-Eluting Stent Product and Services
Table 26. B. Braun Melsungen Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. B. Braun Melsungen Recent Developments/Updates
Table 28. MicroPort Scientific Basic Information, Manufacturing Base and Competitors
Table 29. MicroPort Scientific Major Business
Table 30. MicroPort Scientific Drug-Eluting Stent Product and Services
Table 31. MicroPort Scientific Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MicroPort Scientific Recent Developments/Updates
Table 33. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 34. Cook Medical Major Business
Table 35. Cook Medical Drug-Eluting Stent Product and Services
Table 36. Cook Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cook Medical Recent Developments/Updates
Table 38. Terumo Basic Information, Manufacturing Base and Competitors
Table 39. Terumo Major Business
Table 40. Terumo Drug-Eluting Stent Product and Services
Table 41. Terumo Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Terumo Recent Developments/Updates
Table 43. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 44. Biosensors International Major Business
Table 45. Biosensors International Drug-Eluting Stent Product and Services
Table 46. Biosensors International Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biosensors International Recent Developments/Updates
Table 48. Balton Basic Information, Manufacturing Base and Competitors
Table 49. Balton Major Business
Table 50. Balton Drug-Eluting Stent Product and Services
Table 51. Balton Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Balton Recent Developments/Updates
Table 53. AlviMedica Medical Technologies Basic Information, Manufacturing Base and Competitors
Table 54. AlviMedica Medical Technologies Major Business
Table 55. AlviMedica Medical Technologies Drug-Eluting Stent Product and Services
Table 56. AlviMedica Medical Technologies Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. AlviMedica Medical Technologies Recent Developments/Updates
Table 58. Biotronik Basic Information, Manufacturing Base and Competitors
Table 59. Biotronik Major Business
Table 60. Biotronik Drug-Eluting Stent Product and Services
Table 61. Biotronik Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biotronik Recent Developments/Updates
Table 63. Shandong JW Medical Basic Information, Manufacturing Base and Competitors
Table 64. Shandong JW Medical Major Business
Table 65. Shandong JW Medical Drug-Eluting Stent Product and Services
Table 66. Shandong JW Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shandong JW Medical Recent Developments/Updates
Table 68. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 69. Sino Medical Major Business
Table 70. Sino Medical Drug-Eluting Stent Product and Services
Table 71. Sino Medical Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sino Medical Recent Developments/Updates
Table 73. Beijing AMSINO Basic Information, Manufacturing Base and Competitors
Table 74. Beijing AMSINO Major Business
Table 75. Beijing AMSINO Drug-Eluting Stent Product and Services
Table 76. Beijing AMSINO Drug-Eluting Stent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Beijing AMSINO Recent Developments/Updates
Table 78. Global Drug-Eluting Stent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Drug-Eluting Stent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Drug-Eluting Stent Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Drug-Eluting Stent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Drug-Eluting Stent Production Site of Key Manufacturer
Table 83. Drug-Eluting Stent Market: Company Product Type Footprint
Table 84. Drug-Eluting Stent Market: Company Product Application Footprint
Table 85. Drug-Eluting Stent New Market Entrants and Barriers to Market Entry
Table 86. Drug-Eluting Stent Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Drug-Eluting Stent Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Drug-Eluting Stent Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Drug-Eluting Stent Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Drug-Eluting Stent Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Drug-Eluting Stent Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Drug-Eluting Stent Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Drug-Eluting Stent Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Drug-Eluting Stent Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Drug-Eluting Stent Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Drug-Eluting Stent Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Drug-Eluting Stent Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Drug-Eluting Stent Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Drug-Eluting Stent Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Drug-Eluting Stent Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Drug-Eluting Stent Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Drug-Eluting Stent Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Drug-Eluting Stent Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Drug-Eluting Stent Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Drug-Eluting Stent Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Drug-Eluting Stent Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Drug-Eluting Stent Raw Material
Table 146. Key Manufacturers of Drug-Eluting Stent Raw Materials
Table 147. Drug-Eluting Stent Typical Distributors
Table 148. Drug-Eluting Stent Typical Customers
LIST OF FIGURES
Figure 1. Drug-Eluting Stent Picture
Figure 2. Global Drug-Eluting Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drug-Eluting Stent Consumption Value Market Share by Type in 2022
Figure 4. Rapamycin Eluting Stent Examples
Figure 5. Paclitaxel Eluting Stent Examples
Figure 6. Everolimus Eluting Stent Examples
Figure 7. Others Examples
Figure 8. Global Drug-Eluting Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Drug-Eluting Stent Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Ambulatory Surgical Centers Examples
Figure 13. Others Examples
Figure 14. Global Drug-Eluting Stent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Drug-Eluting Stent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Drug-Eluting Stent Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Drug-Eluting Stent Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Drug-Eluting Stent Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Drug-Eluting Stent Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Drug-Eluting Stent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Drug-Eluting Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Drug-Eluting Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Drug-Eluting Stent Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Drug-Eluting Stent Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Drug-Eluting Stent Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Drug-Eluting Stent Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 56. China Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Drug-Eluting Stent Market Drivers
Figure 77. Drug-Eluting Stent Market Restraints
Figure 78. Drug-Eluting Stent Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2022
Figure 81. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 82. Drug-Eluting Stent Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Drug-Eluting Stent Picture
Figure 2. Global Drug-Eluting Stent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Drug-Eluting Stent Consumption Value Market Share by Type in 2022
Figure 4. Rapamycin Eluting Stent Examples
Figure 5. Paclitaxel Eluting Stent Examples
Figure 6. Everolimus Eluting Stent Examples
Figure 7. Others Examples
Figure 8. Global Drug-Eluting Stent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Drug-Eluting Stent Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Ambulatory Surgical Centers Examples
Figure 13. Others Examples
Figure 14. Global Drug-Eluting Stent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Drug-Eluting Stent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Drug-Eluting Stent Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Drug-Eluting Stent Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Drug-Eluting Stent Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Drug-Eluting Stent Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Drug-Eluting Stent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Drug-Eluting Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Drug-Eluting Stent Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Drug-Eluting Stent Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Drug-Eluting Stent Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Drug-Eluting Stent Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Drug-Eluting Stent Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Drug-Eluting Stent Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 56. China Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Drug-Eluting Stent Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Drug-Eluting Stent Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Drug-Eluting Stent Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Drug-Eluting Stent Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Drug-Eluting Stent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Drug-Eluting Stent Market Drivers
Figure 77. Drug-Eluting Stent Market Restraints
Figure 78. Drug-Eluting Stent Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drug-Eluting Stent in 2022
Figure 81. Manufacturing Process Analysis of Drug-Eluting Stent
Figure 82. Drug-Eluting Stent Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
